TECHNIQUES FOR MODELLING AND OPTIMIZING DIALYSIS TOXIN DISPLACER COMPOUNDS

Patent №

US 11,640,846

Granted

2023-05-02

Filed 2021

Owner

FRESENIUS MEDICAL CARE HOLDINGS, INC.

Lab

AI components

2

planning · hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

17162030

Systems, methods, and/or apparatuses may be operative to perform a dialysis process that includes a displacer infusion process. In one embodiment, a method for determining a displacer compound may include constructing a plurality of target protein quantitative structure-activity relationship (QSAR) models, one for each of the plurality of binding sites, analyzing a set of candidate compounds using the plurality of QSAR models to determine a set of at least one potential compound with an affinity for binding to each of the plurality of binding sites, and selecting at least one displacer compound from the set of at least one potential compound. Other embodiments are described.

PlanningAI hardwareG16B 15/30A61M 1/1613A61M 1/1676G16B 5/20G16C 20/30G16H 20/17G16H 20/40G16H 50/50+2 more

AI classification

Planning0.95
AI hardware0.91
Machine learning0.03
Evolutionary computation0.03
Knowledge representation0.02
Natural language0.01
Vision0.00
Speech0.00

Ownership

FRESENIUS MEDICAL CARE HOLDINGS, INC.

assignment · 563730518

Assignors

TAO, XIA, MAHESHWARI, VAIBHAV, KOTANKO, PETER, THIJSSEN, STEPHAN, GROBE, NADJA

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC